10 stories mentioning HSICUpdated 6d ago
Every FINWIRES story that references HSIC, newest first.
Henry Schein (HSIC) shares rose 1.7% in Thursday afternoon trading after BTIG upgraded the health care products distributor to buy from neutral, with a price target of $100.Trading volume stood at over 1 million shares, compared with a daily average of about 1.4 million shares.Price: $80.16, Change: $+1.31, Percent Change: +1.66%
Henry Schein (HSIC) has an average rating of overweight and mean price target of $88.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target of $81 (down from $82), is 13.7x our 2027 EPS estimate, between HSIC's three- and five-year historical forward averages of 13.4x and 14.4x, respectively, balancing operational challenges and near-term growth headwinds with expectations of stable market conditions and gradual profitability improvement from restructuring initiatives, in our view. HSIC maintained 2026 guidance following Q1 results that beat consensus expectations despite modest growth in U.S. Medical due to a less severe cold/flu season. The company is approaching its goal of having high-growth, high-margin businesses contribute 50% of total operating income, a key part of its BOLD+1 strategy. In addition, HSIC expects to complete the U.S. rollout of its henryschein.com platform by the end of August 2026. However, management noted rising oil prices as a risk that could affect freight costs and product pricing. We raise our 2026 EPS view to $5.34 from $5.32 and keep 2027 at $5.91.
Henry Schein (HSIC) has an average rating of overweight and mean price target of $87.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $75.38, Change: $+1.01, Percent Change: +1.36%
Henry Schein (HSIC) has an average rating of overweight and mean price target of $90.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $74.05, Change: $+2.03, Percent Change: +2.82%
Henry Schein (HSIC) has an average rating of overweight and mean price target of $90.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $73.86, Change: $+1.84, Percent Change: +2.55%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Henry Schein reported Q1 adjusted EPS of $1.32, up 14.8% Y/Y and $0.10 above consensus, while total net sales increased 6.3% Y/Y to $3.368B. Adjusted operating margin expanded 28 bps to 7.53%, supported by improvement in Global Distribution and Technology segments. We view the dental distribution strength as encouraging, with Global Dental sales rising 9.0% Y/Y to $1.766B and equipment sales up 8.6% despite the challenging higher interest rate environment pressuring equipment purchases. We believe the dental equipment growth of 8.6% Y/Y represents a positive indicator given financing constraints on buyers, while the Global Technology segment's 7.0% Y/Y growth reflects increased adoption of practice management solutions. Management reaffirmed 2026 guidance for sales, margins, and EPS. HSIC maintained its aggressive capital return strategy, repurchasing $125M of shares during Q1 with $655M remaining under authorization.
Henry Schein (HSIC) has an average rating of overweight and mean price target of $90.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $76.88, Change: $-1.34, Percent Change: -1.71%
Henry Schein (HSIC) has an average rating of overweight and mean price target of $90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Henry Schein (HSIC) has an average rating of overweight and mean price target of $89.23, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
